Cargando…

Belatacept and mediastinal histoplasmosis in a kidney transplant patient

Background: In transplantation immunosuppression enhances the appearance of opportunist infections. An ideal balance between the prevention of rejection, the lowest risk of infections and the highest rates of graft survival is a continuous challenge. Lower doses of immunosuppression may diminish the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trimarchi, Hernán, Rengel, Tatiana, Andrews, José, Paulero, Matías, Iotti, Alejandro, Forastiero, Agustina, Lombi, Fernando, Pomeranz, Vanesa, Forrester, Mariano, Iriarte, Romina, Agorio, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Diabetic Nephropathy Prevention 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844914/ https://www.ncbi.nlm.nih.gov/pubmed/27152295 http://dx.doi.org/10.15171/jnp.2016.15

Ejemplares similares

In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia
por: Trimarchi, Hernán, et al.
Publicado: (2017)

Mucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis
por: Trimarchi, H., et al.
Publicado: (2018)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?
por: Trimarchi, Hernán, et al.
Publicado: (2012)

Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease
por: Trimarchi, Hernán, et al.
Publicado: (2017)

Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
por: Trimarchi, H., et al.
Publicado: (2016)

Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis
por: Trimarchi, Hernán, et al.
Publicado: (2011)

In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
por: Trimarchi, H., et al.
Publicado: (2017)

Increased urinary CD80 excretion and podocyturia in Fabry disease
por: Trimarchi, H., et al.
Publicado: (2016)

Initially Nondiagnosed Fabry's Disease when Electron Microscopy Is Lacking: The Continuing Story of Focal and Segmental Glomerulosclerosis
por: Trimarchi, H., et al.
Publicado: (2013)

Proteinuria and its relation to diverse biomarkers and body mass index in chronic hemodialysis
por: Trimarchi, Hernán, et al.
Publicado: (2013)

Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease
por: Trimarchi, H., et al.
Publicado: (2015)

Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR
por: Trimarchi, H., et al.
Publicado: (2014)

Proteinuria, (99m)Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease
por: Trimarchi, Hernán, et al.
Publicado: (2014)

Fibrosing Mediastinitis: Uncommon Life-threatening Complication of Histoplasmosis
por: Khalid, Muhammad, et al.
Publicado: (2018)

An Unusual Clinical Outcome and Surgical Intervention for Mediastinal Histoplasmosis
por: Katsiroubas, Jessica, et al.
Publicado: (2022)

Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)

Belatacept: the challenges with transformational drugs
por: Vincenti, Flavio
Publicado: (2017)

Belatacept: A worthy alternative to cyclosporine?
por: Melvin, George, et al.
Publicado: (2012)

Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014)

Belatacept in renal transplantation—quo vadis?
por: Westhoff, Timm H.
Publicado: (2016)

Belatacept Conversion in Kidney After Liver Transplantation
por: Cristea, Octav, et al.
Publicado: (2021)

A case of belatacept-induced chilblain lupus
por: Kinariwalla, Neha, et al.
Publicado: (2022)

Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
por: Ashokkumar, Chethan, et al.
Publicado: (2015)

CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
por: Silva, Marcos V., et al.
Publicado: (2012)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients
por: Shen, Jinshan, et al.
Publicado: (2013)

Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants
por: Kumar, Dhiren, et al.
Publicado: (2017)

Belatacept: Coronavirus disease 2019 (COVID-19): case report
Publicado: (2020)

Conversion to belatacept after lung transplantation: Report of 10 cases
por: Brugière, Olivier, et al.
Publicado: (2023)

Oral histoplasmosis
por: Patil, Karthikeya, et al.
Publicado: (2009)

Disseminated histoplasmosis
por: Mansoor, C A, et al.
Publicado: (2013)

Oral histoplasmosis
por: Momesso, Gustavo Antonio Correa, et al.
Publicado: (2017)

Histoplasmosis of the gallbladder
por: Claassen, Cassidy, et al.
Publicado: (2019)

Histoplasmosis of the Larynx
por: Pochini Sobrinho, Fernando, et al.
Publicado: (2015)

Pulmonary Histoplasmosis
por: Cataño, Juan, et al.
Publicado: (2023)

Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation
por: Grannas, Gerrit, et al.
Publicado: (2014)

Stricturing Crohn’s disease-like colitis in a patient treated with belatacept
por: Bozon, Anne, et al.
Publicado: (2017)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3il1jjgj17hfvt0k2qjmlmopqi